MoneyWorks4Me

Earum Pharmaceutical - Quaterly Results

14 Jul 2022 Evaluate
The sales surged to Rs. 42.79 millions, up 43.25% for the June 2022 quarter as against Rs. 29.87 millions during the corresponding quarter previous year.The Total Profit for the quarter ended June 2022 of Rs. 3.62 millions grew from Rs.-37.41 millions Operating profit Margin for the quarter ended June 2022 improved to 3.86% as compared to -33.08% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 42.79 29.87 43.25 42.79 29.87 43.25 210.36 410.84 -48.80
Other Income 8.66 0.83 943.37 8.66 0.83 943.37 77.03 89.32 -13.76
PBIDT 3.86 -33.08 -111.67 3.86 -33.08 -111.67 32.83 11.71 180.36
Interest 0.00 0.73 0.00 0.00 0.73 0.00 0.82 9.31 -91.19
PBDT 3.86 -33.81 -111.42 3.86 -33.81 -111.42 32.01 2.40 1233.75
Depreciation 0.24 0.32 -25.00 0.24 0.32 -25.00 1.18 1.23 -4.07
PBT 3.62 -34.13 -110.61 3.62 -34.13 -110.61 30.83 1.17 2535.04
TAX 0.00 3.28 0.00 0.00 3.28 0.00 8.58 0.29 2858.62
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 3.62 -37.41 -109.68 3.62 -37.41 -109.68 22.25 0.88 2428.41
Equity 123.36 61.68 100.00 123.36 61.68 100.00 123.36 61.68 100.00
PBIDTM(%) 9.02 -110.75 -108.15 9.02 -110.75 -108.15 15.61 2.85 447.54
Peers